Welcome to Myopharm, a clinical stage company with a strong clinical pipeline in preventing metabolic diseases.
Myopharm have expert management coupled with efficient business models and an ambitious roadmap. R&D and manufacturing, are the core of our development. Myopharm believe in long and sustainable partnerships.
With the sharp rise in Prediabetes and Type 2 diabetes globally, Myopharm believe that your health can not afford to wait.
View our Share Registry here.
Get the latest news from Myopharm directly to your inbox.
To contact us please click here.